Solid dosage forms that contain clathrates of 17amp;agr;-ethinyl estradiol

摘要

A method and pharmaceutical compositions are disclosed for reducing oxidative degradation of 17 &agr;-ethinylestradiol comprising combining the estradiol with an effective amount of cyclodextrin, thus forming a cyclodextrin clathrate of the steroid.